Abstract: A medical image apparatus according to an embodiment of the present disclosure includes a main body that is travelable, a column vertically coupled to the main body, a straight arm moving unit sliding in a longitudinal direction of the column, a straight arm coupled to the straight arm moving unit and rotating with respect to the column, and a source arm located on a side of the straight arm, perpendicular to the straight arm, and including a source driving rail through which a source assembly slides, wherein the straight arm is coupled to a moving unit rotating shaft formed on the straight arm moving unit, and is rotatable with respect to the column about the moving unit rotating shaft, and the source arm is fixed to the side of the straight arm.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating periodontal disease, comprising horse chestnut extract as effective component, and a food composition for preventing or improving periodontal disease, comprising horse chestnut extract as effective component, wherein the horse chestnut extract comprises avicularin and juglanin as active ingredients.

Abstract: A medical image apparatus includes a column coupled to a main body and vertically extending, a straight arm moving unit sliding in a longitudinal direction of the column and including a moving unit rotating shaft for rotating a straight arm, and the straight arm coupled to the straight arm moving unit and rotating with respect to the column. The straight arm moving unit includes a camshaft formed along a side surface of the moving unit rotating shaft, having an elliptical cross-section, and fixed to the straight arm moving unit, the straight arm includes a first balance unit and a second balance unit fixed to the straight arm, contacting a side surface of the camshaft, and configured to press the side surface of the camshaft by an elastic body. The first balance unit presses a side of the camshaft and the second balance unit presses the other side of the camshaft.

Abstract: A medical image apparatus according to an embodiment of the present disclosure includes a main body that is travelable, a column vertically coupled to the main body, a straight arm moving unit sliding in a longitudinal direction of the column, a straight arm coupled to the straight arm moving unit and rotating with respect to the column, and a source arm located on a side of the straight arm, perpendicular to the straight arm, and including a source driving rail through which a source assembly slides, wherein the straight arm is coupled to a moving unit rotating shaft formed on the straight arm moving unit, and is rotatable with respect to the column about the moving unit rotating shaft, and the source arm is fixed to the side of the straight arm.

Abstract: The present invention relates to a fraction extract of Melissa officinalis leaves, and a novel pharmaceutical composition and a food composition that include same.

Abstract: The present application describes an ethyl acetate fraction of Melissa leaf having excellent angiogenesis and MMP inhibitory activities, and a composition comprising the same.

Abstract: The present application describes an ethyl acetate fraction of Melissa leaf having excellent angiogenesis and MMP inhibitory activities, and a composition comprising the same.

Abstract: The present application describes an ethyl acetate fraction of Melissa leaf having excellent angiogenesis and MMP inhibitory activities, and a composition comprising the same.

Abstract: A ballast water treatment operating apparatus includes a ballast water treatment unit for performing a certain treatment of ballast water flowing in from the outside for a ballast operation or performing a certain treatment of ballast water discharged into the outside for a de-ballast operation; a positional information receiving unit for receiving positional information; a control unit for confirming a ship's position by using positional information received from the positional information receiving unit and then determining whether to operate the ballast water treatment unit during a ballast operation or during a de-ballast operation, thereby being capable of preventing an unnecessary energy consumption.

Abstract: The present invention relates to a composition containing Horse chestnut extract that inhibits angiogenesis and matrix metalloproteinase activity. The Horse chestnut extract of the present invention inhibits angiogenesis and activity of matrix metalloproteinase, so that it can be applied to treat and prevent disease related to angiogenesis and/or matrix metalloproteinase.

Abstract: A ballast water treatment operating apparatus includes a ballast water treatment unit for performing a certain treatment of ballast water flowing in from the outside for a ballast operation or performing a certain treatment of ballast water discharged into the outside for a de-ballast operation; a positional information receiving unit for receiving positional information; a control unit for confirming a ship's position by using positional information received from the positional information receiving unit and then determining whether to operate the ballast water treatment unit during a ballast operation or during a de-ballast operation, thereby being capable of preventing an unnecessary energy consumption.

Abstract: The present application describes an ethyl acetate fraction of Melissa leaf having excellent angiogenesis and MMP inhibitory activities, and a composition comprising the same.

Abstract: The present invention relates to a composition comprising Melissa leaf extract that inhibits angiogenesis and matrix metalloproteinase activity. The Melissa leaf extract of the present invention inhibits angiogenesis and activity of matrix metalloproteinase, so that it can be applied to treat or prevent diseases related to angiogenesis and matrix metalloproteinase. The composition of the present invention comprising Melissa leaf extract may also comprise more than one component of the other anti-angiogenic, anti-cancer, anti-inflammatory and anti-aging components. This particular composition comprising Melissa leaf extract can be used for pharmaceutical, dietetic and/or cosmetic purposes.

Abstract: The present invention provides a human serum albumin-TIMP2 fusion protein having the amino acid sequence set forth in SEQ ID NO. 10, a polynucleotide encoding the same and a vector comprising the polynucleotide, a host cell transformed with the vector, a method for producing the human serum albumin-TIMP2 fusion protein and a pharmaceutical composition comprising the human serum albumin-TIMP2 fusion protein. The human serum albumin-TIMP2 fusion protein is stable and retains the activity of TIMP2, thus it can be used as a pharmaceutical composition to treat diseases related to angiogenesis and/or metastasis of cancer cells.

Abstract: The present invention provides a human serum albumin-TIMP2 fusion protein having the amino acid sequence set forth in SEQ ID NO. 10, a polynucleotide encoding the same and a vector comprising the polynucleotide, a host cell transformed with the vector, a method for producing the human serum albumin-TIMP2 fusion protein and a pharmaceutical composition comprising the human serum albumin-TIMP2 fusion protein. The human serum albumin-TIMP2 fusion protein is stable and retains the activity of TIMP2, thus it can be used as a pharmaceutical composition to treat diseases related to angiogenesis and/or metastasis of cancer cells.

Abstract: The present invention relates to a composition containing Horse chestnut extract that inhibits angiogenesis and matrix metalloproteinase activity. The Horse chestnut extract of the present invention inhibits angiogenesis and activity of matrix metalloproteinase, so that it can be applied to treat and prevent disease related to angiogenesis and/or matrix metalloproteinase.

Abstract: The present invention relates to a composition containing ginkgo biloba extract that inhibit angiogenesis and matrix metalloproteinases. The ginkgo biloba extract of the present invention suppress angiogenesis and activity of matrix metalloproteinases, so that it can be applied to medicine for disease related in angiogenesis and matrix metalloproteinases.

Abstract: The present invention relates to a composition comprising Melissa leaf extract that inhibits angiogenesis and matrix metalloproteinase activity. The Melissa leaf extract of the present invention inhibits angiogenesis and activity of matrix metalloproteinase, so that it can be applied to treat or prevent diseases related to angiogenesis and matrix metalloproteinase. The composition of the present invention comprising Melissa leaf extract may also comprise more than one component of the other anti-angiogenic, anti-cancer, anti-inflammatory and anti-aging components. This particular composition comprising Melissa leaf extract can be used for pharmaceutical, dietetic and/or cosmetic purposes.